Estimated wasteful spending on aducanumab dispensing in the U.S. Medicare population: A cross-sectional analysis

J Am Geriatr Soc. 2022 Sep;70(9):2714-2718. doi: 10.1111/jgs.17891. Epub 2022 Jun 27.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antibodies, Monoclonal, Humanized* / therapeutic use
  • Cross-Sectional Studies
  • Health Expenditures
  • Humans
  • Medicare*
  • United States

Substances

  • Antibodies, Monoclonal, Humanized
  • aducanumab